Programmed cell death is a fundamental process for the development and somatic maintenance of organisms. This unit describes methods for visualizing both dying cells in situ and for detection of nucleosomal ladders. A description of various current detection strategies is provided, as well as support protocols for preparing positive and negative controls and for preparing genomic DNA.
INTRODUCTION
A universal feature in the development of multicellular organisms is a physiological form of cell death termed programmed cell death (PCD). A subset of PCD is apoptosis, which is defined by characteristic cellular morphological changes and genomic DNA fragmentation producing nucleosomal ladders. To understand how PCD operates in a developing tissue or in a tissue following an experimental procedure, dying cells must be identified in relation to their surviving neighbors. One way to accomplish this is to visualize fragmented DNA in situ, in combination with independent approaches such as gel electrophoresis of isolated DNA to visualize the nucleosomal ladders associated with apoptosis.
Two protocols for assessing apoptosis are presented in this unit. In situ end-labeling plus (ISEL+), a technique that originated from studies of central nervous system (CNS) tissue, identifies dying cells in tissue sections or cell culture (optimized for embryonic samples; see Basic Protocol 1). Ligation-mediated polymerase chain reaction (LMPCR) identifies nucleosomal ladders from intact tissues (see Basic Protocol 2). Also included are protocols for preparing thymocyte cell cultures for use as controls in the ISEL+ procedure (see Support Protocol 1) and for isolating genomic DNA for LMPCR (see Support Protocol 2).
NOTE: All protocols using live animals must be reviewed and approved by an Institutional Animal Care and Use Committee (IACUC) and must follow officially approved procedures for the care and use of laboratory animals.
NOTE:
Use of human tissues requires appropriate IRB approval. Possible biosafety and biohazardous materials must also be similarly considered by the appropriate oversight committee. • C Slide-processing holders and vessels 80
STRATEGIC PLANNING
• C vacuum oven with house vacuum/pump 24-well microtiter plates (if using coverslip-mounted cells as controls) Airtight containers for slide storage with desiccant (Tupperware) Humidified chamber for microscope slides Coverslips Microscope, preferably equipped for brightfield, DIC, and/or fluorescence CAUTION: Paraformaldehyde, triethanolamine, acetic anhydride, and potassium cacodylate (in the TdT buffer) are toxic and must be used in accordance with safety standards.
Prepare tissue
1. Harvest embryos (or other tissues) using fine scissors and forceps by laparotomy, uterine exposure, and careful incision of the uterus. Remove one embryo at a time, taking care not to rupture the amniotic sacs or transect the umbilical cords (and umbilical arteries/veins) of other embryos, so as to keep individual embryos bloodperfused as long as possible. For tissues requiring dissection, place tissue in ice-cold DMEM (or similar dissection medium). Rapidly isolate the tissue (within minutes, faster is better) and place it in ice-cold embedding medium preferably in a freezing mold using blunt forceps and/or spatula; embryos too small to dissect easily can be placed directly into embedding medium. 3. Cut sections using a cryostat with a sharp blade to produce 10-μm-thick sections (see UNIT 1.1).
Substandard cutting blades can result in artifacts produced by tissue damage.
4. After cutting, position the slide carefully over the section, thaw in place, and place on the 50 • C slide warmer until ready for the next section. When all the slides have been collected, place slides in a slide rack and bake them in a preheated vacuum oven for 1 hr at 80 • C under house vacuum. 
PREPARATION OF THYMOCYTE CELL CULTURES FOR ISEL+
To obtain primary thymocyte cultures, thymus cells are grown on 12-mm round glass coverslips (coated with a desired adhesive, e.g., poly-L-lysine or Cell-Tak). The cultures are then treated with dexamethasone to induce apoptosis. They can then be used as a positive control and compared with untreated thymocyte cultures being assessed for programmed cell death (see Basic Protocol 1). 2. Centrifuge cells 5 min at 800 × g, room temperature, remove trypsin medium, and resuspend resulting pellet in 2 ml DMEM/F-12/5% FBS.
Count cells (APPENDIX 3B)
, adjust concentration to 2 × 10 6 cells per well, and plate cells on coated 12-mm coverslips placed in 24-well microtiter dishes.
4. Add 1 μM dexamethasone (from 2 mM stock in ethanol) and incubate 4 hr in a humidified 37 • C, 5% CO 2 incubator. 
DETECTION OF NUCLEOSOMAL LADDERS ASSOCIATED WITH PROGRAMMED CELL DEATH BY LIGATION-MEDIATED POLYMERASE CHAIN REACTION (LMPCR)
DNA ladders with nucleosomal-sized rungs are a hallmark of apoptosis, but ladders can be difficult to visualize in tissues where apoptosis is nonsynchronous, such as in developing tissues. In addition, a significant amount of starting tissue is generally required to isolate enough DNA for precise analyses. Most ladder rungs appear to be blunt ended and 5 -phosphorylated on each end, allowing their identification by ligation of artificial, dephosphorylated linkers followed by amplification using the polymerase chain reaction (PCR). The resulting amplified DNA is visualized by agarose gel electrophoresis and ethidium bromide staining. CAUTION: Ethidium bromide is a mutagen and should be handled, stored, and disposed of with appropriate care.
Materials

Ligate linkers
1. Combine in a 0.5-ml microcentrifuge tube:
≤2.5 μg genomic DNA ≤1 nmol 12-bp unphosphorylated oligonucleotide ≤1 nmol 24-bp unphosphorylated oligonucleotide 6 μl 10× T4 DNA ligase buffer dH 2 O to 60 μl. 4. Heat mixture 5 min more at 55 • C in the thermal cycler.
Mix thoroughly.
5. Slowly cool mixture to 10 • C over a 55-min period, and incubate at least 10 min at 10 • C. Staley et al. (1997) for more information.
ISOLATION OF GENOMIC DNA FROM TISSUES AND CULTURES
Analysis of DNA by LMPCR requires its isolation from intact tissues or cells in culture.
Tissues are rapidly frozen in liquid nitrogen and pulverized using a liquid nitrogencooled mortar and pestle; then the cells are lysed in warmed SDS/proteinase K buffer. Cultured cells are not frozen; instead they are immediately lysed in SDS/proteinase K buffer, and the resulting slurry is incubated overnight and processed like tissues. In both cases, after an overnight incubation with agitation, the DNA solution is extracted with phenol/chloroform, precipitated, washed, resuspended, quantified, and used for LMPCR in Basic Protocol 2. 6. Quantify DNA samples using a DNA-specific fluorescent dye and fluorometer, or other accurate methodology. Digestion of RNA with DNase-free RNase A, followed by reprecipitation, and quantification using a spectrophotometer may also be used (see APPENDIX 1K). H 2 O to 80 ml Store up to 6 months at −20 • C Just before use, dilute to 1×, adding: 10 mM 2-mercaptoethanol 100 μg/ml BSA (from 1 mg/ml stock; see recipe) 32 μg/ml 10 mM 4-dNTP mix (320 μM final)
Materials
REAGENTS AND SOLUTIONS
Alternatively, buffer may be included with the purchased Taq enzyme. 
SDS/proteinase K buffer
COMMENTARY Background Information
Programmed cell death (PCD) is the physiological elimination of cells by death (Wyllie, 1981; Ucker, 1991) . Apoptosis is the best-known form of PCD and is characterized morphologically by nuclear size reduction, blebbing of the cellular membrane, chromatin condensation, and the formation of nucleosome-sized fragments of genomic DNA, detectable by gel electrophoresis (Kerr et al., 1972 (Kerr et al., , 1994 Morris et al., 1984) . Other forms of PCD also exist. Autophagy (Bursch et al., 2000) is thought to be distinct from apoptosis by involving the combined destruction of
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Supplement 48 Current Protocols in Neuroscience the Golgi apparatus, polyribosomes, and endoplasmic reticulum, but with preservation of mitochondrial and micro-and intermediate filaments. Caspase-independent forms of PCD also exist (Liang et al., 2008) . Evidence for the occurrence of PCD has been found in every multicellular organism studied, from flies to worms to mammals (Oppenheim, 1985; Ellis and Horvitz, 1986; Raff et al., 1993; White et al., 1994; Blaschke et al., 1996; Staley et al., 1997) . All forms of PCD involve some degree of DNA fragmentation. A significant advance in the study of PCD has been the development of histological techniques that localize DNA strand breaks within dying cells (Gavrieli et al., 1992; Wijsman et al., 1993; Wood et al., 1993) . The first such technique, TdT-mediated dUTP nick-end labeling (TUNEL; Gavrieli et al., 1992; Strater et al., 1995; Negoescu et al., 1996) , employed the template-independent DNA polymerase terminal deoxynucleotidyl transferase (TdT) to attach biotin-labeled nucleotides to the free 3 ends of fragmented DNA. These labeled nucleotides could then be recognized by a peroxidase-conjugated avidin molecule and visualized through a substrate reaction that produced a colored precipitate within the nucleus. TUNEL and related techniques have been used to demonstrate the presence of PCD in many organisms, as well as in tissue culture (Surh and Sprent, 1994; White et al., 1994) . In the nervous system, techniques conceptually related to TUNEL, but employing different polymerases and/or visualization techniques, have also been used to show evidence of PCD in the granule cell layer of the cerebellum (Wood et al., 1993) and in neurodegenerative disorders such as Huntington's disease (Thomas et al., 1995) .
Procedures like TUNEL, as originally published, were unable to identify dying cells to any significant degree within the embryonic cerebral cortex, which, combined with prevailing views at the time, led some to conclude that cell death did not occur there. This disparity led to the development of techniques with improved sensitivity over TUNEL, resulting in in situ end-labeling plus (ISEL+; Blaschke et al., 1996 Blaschke et al., , 1998 and the associated but independent technique of ligation-mediated PCR [(LMPCR; Staley et al., 1997) of DNA ladders. These techniques have proved successful in both tissue preparations and cell cultures at identifying dying cells produced by PCD in the developing nervous system, as well as in other tissues (Staley et al., 1997; Weiner et al., 1998; Vaccarino et al., 1999; Weiner and Chun, 1999; Contos et al., 2000; Gu et al., 2000; Pompeiano et al., 2000; Yan et al., 2000; Kingsbury et al., 2003; McConnell et al., 2004; Chao et al., 2006; Rehen et al., 2006) . Multiple technical differences exist between ISEL+ and the original TUNEL technique (Table 3 .8.1; see also Strategic Planning) that result in a significant increase in sensitivity. Many current commercial kits are in fact hybrids of TUNEL and ISEL+.
It is important to make a distinction between dying versus dead cells. ISEL+ is optimized to detect the former, whereas the original TUNEL protocol generally identifies the latter, e.g., corresponding with pyknotic nuclei. An experiment to examine the latency between DNA fragmentation detected by ISEL+ and actual cell death and removal was conducted in the small intestine, utilizing BrdU birthdating to follow cells after their last cell division (Pompeiano et al., 1998) . The epithelium of the small intestine turns over completely in several days, and the age of epithelial cells increases as one ascends the villus (into the intestinal lumen). Use of this well-defined model system demonstrated that cells destined to die commenced DNA fragmentation 2 to 3 days before they were actually eliminated as dead cells at the villus tip.
The increased level of sensitivity produced by ISEL+ identified significant levels of developmentally variable dying cells, averaging around 50%, within the embryonic cerebral cortex (Blaschke et al., 1996) , as well as throughout the neuraxis (Blaschke et al., 1998) . At the time, this was a surprising result, as it contrasted with prevailing views. However, independent studies using genetic deletion of the pro-apoptotic proteins caspase-3 (Kuida et al., 1996; Pompeiano et al., 2000) or caspase-9 (Kuida et al., 1998; Zaidi et al., 2001 ) resulted in a striking hyperplasia of embryonic brain cells, consistent with the proven functions of the caspases in cell death, and consistent with at least partial rescue of the PCD that had been identified by ISEL+ and LMPCR. These results have been further supported by deletion of more pro-cell death genes, resulting in "big brain" phenotypes like the caspase-null mutants: Apaf 1 (Cecconi et al., 1998; Yoshida et al., 1998) , Bax and Bak (Lindsten et al., 2003) , Pten (Groszer et al., 2001) , as well as novel pathways involving the ephrins (Depaepe et al., 2005) . Similarly, anti-cell-death genes, when genetically removed, resulted in smaller brains or progenitor pools, as observed for Bcl-X (Motoyama et al., 1995) , Survivin (Jiang et al., 2005) , and Mcl-1 (Arbour et al., 2008) . Further evidence supporting extensive neural cell death comes from examination of single clones identified using a transgenic, mutant lacZ reversion construct (Wilkie et al., 2004 ). An unanticipated, marked decrease in the proportion of embryos with labeled clones was found during early neurogenesis, which is consistent with significant cell death during this period, as identified by ISEL+.
Sensitivity of ISEL+
The most significant advantage of ISEL+ is its sensitivity in detecting dying cells. ISEL+ is up to ten times more sensitive than TUNEL. Figure 3 .8.2 shows a comparison between TUNEL and ISEL+ in an adult mouse thymus treated in vivo with the corticosteroid dexamethasone (DX). DX causes rapid apoptosis of all immature thymocytes within the cortex (outer portion) of the thymus (Surh and Sprent, 1994) and, under the employed experimental conditions, should kill the majority of thymic cortical cells. In identically treated thymi, TUNEL identified a number of dying cells in the thymic cortex (Fig. 3.8.2A ), but ISEL+ labeling (Fig. 3.8.2B ) showed many more dying thymocytes; thus, the extent of PCD was more accurately revealed by ISEL+. A parallel time-course study of TUNEL and ISEL+ labeling in DX-treated thymic cultures further demonstrated the relatively greater sensitivity of ISEL+ (Fig. 3.8.3) . TUNEL (Fig.  3.8 .3A-C) did not detect increased cell death until 4 hr after DX addition, while ISEL+ (Fig. 3.8.3 D-F) detected the occurrence of increased apoptosis within 30 min of treatment. These results demonstrate that ISEL+ identifies dying cells with greater sensitivity than does TUNEL.
To quantify the relative difference in sensitivity between ISEL+ and TUNEL, the number of fragmented DNA ends that are required for visualization of a dying cell using each technique was estimated. A 1013-bp linearized fragment of plasmid DNA was labeled in solution by either TUNEL or ISEL+. Known amounts of labeled fragment were electrophoresed on an agarose gel and transferred to nitrocellulose. Labeled fragments were then detected either by TUNEL or by ISEL+. Using this assay (Fig. 3.8.4) , 10 ng of labeled DNA were barely detectable by TUNEL, but prominently detected by ISEL+, which has a limit of detection approaching 1 ng (DNA content measured using a fluorometer). A conservative estimate was obtained of the number of fragmented ends that are required in a single cell for labeling by ISEL+, based on the following calculation. The number of ends in one nanogram of 1013-bp DNA (1.50 × 10 −15 mol) is 1.80 × 10 9 . The area of the blotted DNA band was determined to be 2 × 10 −6 m 2 ; 6.37 × 10 5 cells (with a maximum cross-sectional diameter of 10 −5 m, and an area of 3.14 × 10 −12 m 2 each) would fit into that area. Dividing the number of free ends by the number of cells equates to 3000 ends that (Wyllie, 1981) , ISEL+ labeled virtually all the thymocytes in the cortex. Scale bar = 50 μm. Abbreviations: ctx, thymic cortex; med, thymic medulla.
are required per cell for labeling by ISEL+ at the 1-ng limit of detection, or 30,000 ends per cell at the 10-ng level. Therefore, ISEL+ is approximately ten times more sensitive than TUNEL.
Specificity
The specificity of ISEL+ in the detection of dying cells was examined using the thymus as a model. Under normal conditions, ∼90% of immature thymocytes asynchronously undergo PCD in the cortex of the thymus Shortman et al., 1990) . In vivo exposure of thymus to DX causes immature cortical thymocytes to undergo PCD en masse Shortman et al., 1990) . This drug-induced apoptosis involves essentially all of the thymocytes in the cortex, which proceed synchronously through the cell death pathway. Mature thymocytes, located in the thymic medulla, are insensitive to DX and do not undergo massive PCD (Caelles et al., 1994; Blaschke et al., 1996; Staley et al., 1997) . A normal mouse thymus labeled by ISEL+ identifies a number of labeled cells, consistent with the asynchronous nature of PCD (Fig. 3.8.5A ). In contrast, a thymus treated in vivo with DX and then labeled by ISEL+ identifies a majority of cells (Fig. 3.8 .5B), consistent with the large-scale synchronous cell death induced by DX, as can be seen by the intense labeling of most cells in the thymic cortex. Thus, cells identified by ISEL+ specifically increase in number after a treatment known to increase the number of dying cells.
As an additional example of the specificity of ISEL+, the medulla of a DX-treated thymus is shown (Fig. 3.8 .5B). In this portion of the thymus, cells are insensitive to DX, and, as would be expected, very few cells were labeled by ISEL+. The specificity of ISEL+ has also been addressed in an in vitro paradigm of PCD, in which death was induced in P19 embryonal
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Supplement 48 Current Protocols in Neuroscience carcinoma cells by UV irradiation (Staley et al., 1997) . All of these paradigms also show parallel increases in DNA ladders, identified by both standard and LMPCR techniques (Pompeiano et al., 1998) . Further validation in the small intestine, mentioned above, also supports the specificity of the assay (Blaschke et al., 1996) . These combined data show that ISEL+ is specific in labeling apoptotic cells under the employed biological conditions. It is possible that artifactual or non-biological production of DNA double-strand breaks could produce false-positive signals, as could poor tissue conditions associated with extended post-mortem interval, physical damage, toxicity, etc. Use of independent means of assessing PCD (e.g., appropriate genetic mutants or LMPCR) can minimize errors. Additional controls are shown and discussed in Young (1984) , Crespo et al. (1985) , and Sengelaub et al. (1986) . Some examples are presented below.
Examples of PCD detected by ISEL+
PCD has been studied in a number of neural cell types, and ISEL+ was designed to identify PCD in the nervous system, as shown in several examples from the murine nervous system (Fig. 3.8.6A-C) .
The death of cells in the ganglion layer of the early postnatal rodent retina is well documented (Young, 1984; Sengelaub et al., 1986) , and PCD is prominent during the first 11 days (Flanagan, 1969; Lance-Jones, 1982; Oppenheim, 1985 Oppenheim, , 1989 . In the P1 retina, reportedly a site of high PCD, >60% of ganglion cells were labeled by ISEL+ (Fig. 3.8.6A ), consistent with prior studies.
During the period of limb innervation, spinal cord motor neurons undergo PCD between embryonic days 13 (E13) and E18, and the peak of motor neuron cell death is on E14 (Davies and Lumsden, 1984; Buchman and Davies, 1993) . Many cells are labeled by ISEL+ in the area where motor neurons are differentiating at E14 (Fig. 3.8.6B ).
The developmental period of PCD for trigeminal ganglia is E13 to E18 (Pompeiano et al., 1998) , which corresponds to the period during which synaptic connections are formed.
A trigeminal ganglion at E16 shows a consistent amount of ISEL+ labeling (Fig. 3.8.6C ).
Critical Parameters and Troubleshooting
ISEL+
Tissue isolation: Once deprived of normal nutrient exchange, via diffusion or blood supply, tissues begin to die. It is critical, therefore, to minimize cell death produced by tissue handling. Rapid dissection and use of ice-cold buffers during tissue preparation can help to minimize damage produced during tissue isolation.
Clearance time of labeled cells: The sensitivity of ISEL+ allows one to identify dying cells sooner than with other techniques. Like other techniques, ISEL+ provides static information from a tissue section at a single age from a single animal. Rigorous determination of how a population of cells changes with time, which would require real-time analysis of the same cells in the same animal, cannot therefore be made. Within a tissue section, a cell observed to be labeled on a single day may be just starting to die, midway through its death, or about to be eliminated. The half-life of dying neuroblasts or post-mitotic neurons identified by ISEL+ could range from a few hours to several days, and therefore the actual number of cells eliminated on a given day is uncertain. Based on studies in the small intestinal villus (Pompeiano et al., 1998) , cells labeled by ISEL+ can require up to several days to be eliminated following the onset of PCD, or can be eliminated within hours at the end of the cell death program, which currently serves as the best estimate for interpreting ISEL+ labeling.
Tissue sectioning: Cryostat sections must be of excellent quality. Sections should be cut with a sharp blade to minimize tissue damage and potential artifactual labeling. Thickness should be kept in the range of 10 μm; greater thickness may prevent access of labeling reagents into all cells. Other variables, such as sample and box temperatures within the cryostat, blade angle, anti-roll bar positioning, size of cut block, and ambient temperature and humidity outside the cryostat can all affect tissue sectioning.
Fixation and permeabilization of tissue sections: Over-fixation can block access of labeling reagents, while under-fixation can produce artifactual labeling. Using Basic Protocol 1, a wide variety of tissues has been examined with consistent results; however, fixation can be reexamined empirically to further optimize results. No proteinase treatments are used in this procedure (in contrast to the original TUNEL procedure); the Triton X-100 permeabilization step is therefore critical, because it allows access through both the outer cell and nuclear membranes for DNA labeling.
Acetylation of tissue sections: Background signal primarily arises from nonspecific retention of marker molecules (e.g., dUTP or anti-DIG/AP antibody) in tissue sections. Several chemical functional groups in proteins (such as amine and carboxylate groups) are believed to promote nonspecific binding. In addition, marker molecules may become entrapped within the three-dimensional tissue structure. This source of background can be minimized by treating tissue slides with acetic anhydride to acetylate basic groups. Acetic anhydride is very hygroscopic and hydrolyzes in the presence of water to form acetic acid, thereby neutralizing its acetylation ability. Therefore, fresh acetic anhydride (preferably using newly opened vials) should be used during the preparation of TEA/acetic anhydride.
Terminal deoxynucleotidyl transferase (TdT):
The unit activity of TdT differs between suppliers; even different batches from one supplier can be quite variable. Enough TdT from the same supplier and batch should be obtained to complete an entire experiment without switching batches or suppliers. Like all enzymes, TdT should be stored in a reliable, non-defrosting −20
• C freezer, and maintaining a dedicated stock of the enzyme is recommended.
Immunohistochemical procedures: Two steps are particularly important. First, overnight incubation with anti-digoxigenin gives a substantially stronger and cleaner signal than a 1 hr (or intermediate) incubation, and can be used for maximum sensitivity. Prolonged incubation for color development should be conducted in darkness. Second, alkaline phosphatase, especially associated with a bluish (versus reddish) reaction product, produces the best sensitivity. Other labels can be used (e.g., fluorescence, horseradish peroxidase), but they are less sensitive than the blue alkaline phosphatase product (Fig. 3.8.7A,B) . Fluorescence labeling, however, does allow for detection and co-visualization of other proteins with tagged antibodies.
Sample storage: Embedded samples can be stored at −80
• C for up to several weeks. Cut sections can be stored desiccated for at least several months, provided they are not repeatedly thawed and refrozen. Once reacted for alkaline phosphatase detection, samples should be coverslipped (see protocols above) and can be stored indefinitely.
Labeling of DNA not associated with cell death: In theory, any free DNA end could be labeled by ISEL+. Biologically relevant free ends such as Okazaki fragments do not appear to be labeled, as shown in studies comparing cells undergoing DNA synthesis (identified by BrdU incorporation) to cells labeled by ISEL+ (Blaschke et al., 1996; Staley et al., 1997) . Mitochondrial DNA is circular and does not appear to be labeled. DNA cleavage by procedures like acid nicking (e.g., for anti-BrdU immunohistochemistry) can produce artifactual labeling and should be accounted for before using ISEL+.
LMPCR
All oligonucleotides should be gel-purified to ascertain their correct size before ligation; they may also need to be desalted. Of course, the primers must not be phosphorylated. Be sure to work from the same batch of primers for all the analyzed samples, as differences in ligation efficiency between batches of primers have been observed. It is advisable to use fresh ligase and dNTPs. DNA samples must be washed thoroughly in 70% ethanol to remove salts that can inhibit ligation. Be sure to resuspend the DNA completely after precipitation, washing, and drying. Various thermal cyclers may produce slightly different ramping profiles and they should be assessed accordingly. Use a standard DNA sample with which to compare the tissue in question. In the mouse, DNA from the adult small intestine always produces a very strong signal with 20 cycles or less, while DNA from 2.5-week-old thymus produces a signal after ∼22 cycles.
Anticipated Results
The ISEL+ procedure will result in the visualization of more PCD compared to TUNEL. As discussed above, the clearance time is not well defined for cells labeled by ISEL+. The seemingly high level of PCD identified by ISEL+ has been shown to be a more accurate description of PCD compared to other methodologies, as discussed above. In conjunction with ISEL+, LMPCR provides independent confirmation of the operation of apoptotic mechanisms. Clear nucleosomal ladders can be observed in nervous system tissue similar to those seen in the thymus (Fig. 3.8.8) ; the adult PCD reflects glial and/or subependymal cell PCD (A.J. Blaschke and J. Chun, unpub. observ.) .
Time Considerations
ISEL+
Starting in the morning, the entire procedure can be completed within 3 days; with optimization, and depending on the level of sensitivity required, this should be viewed as an upper limit.
Day 1: Tissue isolation and slide processing Day 2: TdT polymerization and heat inactivation Overnight 2: Anti-digoxigenin incubation Day 3: Visualization of bound antibody and analysis.
LMPCR
Starting in the afternoon, the entire procedure can be completed in 3 days. A B Figure 3 .8.7 ISEL+ using AP and NPT/BCIP colorimetric detection is more sensitive than fluorescence detection. ISEL+ was run in parallel for identical lengths of time using both (A) AP and NPT/BCIP colorimetric detection and using (B) an AlexaFluor 488 (green) tagged secondary antibody on E12 mouse fetal liver to detect clusters of lymphocytes. The signal strength was stronger, the background was cleaner, and more dying cells were detected using colorimetric detection. Positive signal is denoted by dark stain and green fluorescence in the left and right panels, respectively. Scale bar = 100 μm. For color version of this figure go to http://www.currentprotocols.com/protocol/ns0308. Figure 3.8.8 Ligation-mediated PCR (LMPCR) identifies DNA nucleosomal ladders from tissues undergoing apoptosis. Mouse embryonic day E14 and adult brain tissue, as well as 4-week-old mouse thymus, were examined using LMPCR for the presence of nucleosomal ladder as an independent indication of apoptosis. Clear nucleosomal ladders can be seen for embryonic brain and adult thymus tissue, while adult brain showed significantly less intense laddering. A singlecopy gene PCR control is also shown (for engrailed, en), confirming that equivalent amounts of genomic DNA were used for each sample. See Staley et al. (1997) for additional details.
